Limited preventive effect of prednisone on neuropsychiatric symptoms in murine systemic lupus erythematosus

Limited preventive effect of prednisone on neuropsychiatric symptoms in murine systemic lupus erythematosus
复制标题

泼尼松对小鼠系统性红斑狼疮神经精神症状的预防作用有限

DOI:
10.1007/s10787-019-00587-4
复制
发表时间:
2019-03
影响因子:
5.8
通讯作者:
Xu Zhenghao
Xu Zhenghao
中科院分区:
医学2区
文献类型:
--
作者:
Lu Feilong;Lu Haimei;Xie Meijuan;Li Shan;Zu Yunyun;Zhou Jia;Yu Jie;Wang Shuang;Ruan Yeping;Wen Chengping;Xu Zhenghao

文献摘要

参考文献

相似文献

ObjectiveTo investigate whether glucocorticoids, the hallmark medication for systemic lupus erythematosus (SLE), could prevent the development of neuropsychiatric SLE (NPSLE).MethodsThe protective effects of prednisone on NPSLE were tested using the open field, object recognition/placement, forced swim, tail suspension, and sucrose preference tests in MRL/lpr mice. Auto-antibody titres and the weight of lymph nodes were also measured.ResultsMRL/lpr mice exhibited mild depression at the age of 8 weeks before progressing with spatial cognitive impairment and severe depression-like behaviour at the age of 16 weeks. Treating MRL/lpr mice with prednisone (5 mg/kg) from the age of 8 weeks decreased anti-cardiolipin and anti-N-methyl-d-aspartate (NMDA) receptor antibody titres in the brain, reduced the weight of lymph nodes, and prolonged the floating latency in the forced swim test. However, prednisone (3 or 5 mg/kg) had no preventive effect on the development of spatial cognitive impairment and other depression-like behaviours in MRL/lpr mice. The dose of prednisone had a positive correlation with the floating latency in the forced swim test, while it offered no effects on all other behavioural tests.ConclusionOur results provide evidence that early treatment with prednisone had a limited effect on the development of neuropsychiatric symptoms in MRL/lpr mice. Further work is needed in other models beyond NPSLE in MRL/lpr mice before any definitive conclusions are made on the efficacy of prednisone in human NPSLE.
DOI: 10.1016/j.ebiom.2016.11.027
发表时间: 2016-12
期刊: EBIOMEDICINE
影响因子: 11.1
作者:
Xu, Zhenghao;Wang, Yi;Chen, Bin;Xu, Cenglin;Wu, Xiaohua;Wang, Ying;Zhang, Shihong;Hu, Weiwei;Wang, Shuang;Guo, Yi;Zhang, Xiangnan;Luo, Jianhong;Duan, Shumin;Chen, Zhong
通讯作者: Chen, Zhong
DOI: 10.3389/fimmu.2017.00181
发表时间: 2017
影响因子: 7.3
作者:
Ehrenreich H
通讯作者: Ehrenreich H
DOI: 10.1016/s0140-6736(01)05732-4
发表时间: 2001-08
期刊: The Lancet
影响因子: --
作者:
P. Stratta;C. Canavese;S. Santi;G. Ciccone;S. Rosso
通讯作者: P. Stratta;C. Canavese;S. Santi;G. Ciccone;S. Rosso
DOI: 10.1007/s40265-015-0534-3
发表时间: 2016-03
期刊: Drugs
影响因子: 11.5
作者:
Magro-Checa C;Zirkzee EJ;Huizinga TW;Steup-Beekman GM
通讯作者: Steup-Beekman GM
DOI: 10.1186/s12974-015-0423-4
发表时间: 2015-11-06
影响因子: 9.3
作者:
Stock AD;Wen J;Doerner J;Herlitz LC;Gulinello M;Putterman C
通讯作者: Putterman C